Quarter Financials

NeuroSense Therapeutics Ltd. (NRSN)

$1.74

-0.06 (-3.33%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 Q2 2020 Q4
Net Income --
Dividend Paid --
Retained Earnings -7-4

PPE Schedule

Year 2021 Q2 2020 Q4
Capital Expenditure --
Net PPE 00

Intangible and Goodwill Schedule

Year 2021 Q2 2020 Q4
New Purchases --
Intangible and Goodwill --